Fritextsökning
Innehållstyper
-
ATMP-expert till Eliceras styrelse
Karin Hoogendoorn har valts in i styrelsen för Elicera Therapeutics.
-
SDS Life Science satsar på regulatorisk spetskompetens
-
Anna Törner: Kalashnikovs in a new guise
Thanks to resisting European regulatory authorities, Europe has been spared the opioid epidemic. In the 1960s, the situation was the opposite as the American ph...
-
Lucy Robertshaw: Are we in the perfect storm?
“Is there a perfect storm on the horizon again as elective surgeries were cancelled due to patients being admitted with Covid-19? We now have a long backlog of ...
-
Om Life Science Sweden
-
Business Sweden’s new team is rolling out the blue-yellow carpet
According to Business Sweden’s life science team, the combination of substantial medical know-how and an ever-flourishing tech sector is a success factor for Sw...
-
”Jag drivs av att ta fram en produkt som kan säljas i hela världen”
Rankade som nummer ett i världen av WHO inom diarréforskning och snart i fas III-studier för sin vaccinkandidat – Scandinavian Biopharma rusar fram i jakten på ...
-
Automated opening and closing of sample vials
From technical requirements to a suitable solution
-
ALS – When the body has given up, but the brain persists
The nerve disease ALS gradually deprives the patient of control over the muscles and, eventually, also of speech. The eyes continue to function, though, and wit...
-
Collaboration in laboratory automation
The Dutch company Synchron Lab Automation developed an automated DNA extraction system with high throughput, working very closely together with Festo. As a resu...
-
Nya chefer på Xvivo
Anne-Li Sigvardsson och Andreas Wallinder rekryteras inifrån bolaget.
-
Extremely high sample throughput rates
Precision and reliability in automated liquid handling
-
Pharma-on-Demand
Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...
-
Efter positiva resultat för Valneva: ”Ansökan till EMA skickas så snart som möjligt”
Efter att ha stoppats av Storbritannien ser det nu ljusare ut för Valnevas covid-19-vaccinkandidat sedan positiva fas III-resultat presenterats. Nu väntar ansök...
-
Avtalar med Ipsen
Probi tecknar nytt avtal gällande licensiering och distribution av probiotisk bakteriestam.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Läkemedelsupptäckt med CRISPR-screening
-
Giulia Gaudenzi: ”Key lessons from global health research”
The world will still face major challenges in the post Covid-19 pandemic, writes Giulia Gaudenzi at the KTH Division of Nanobiotechnology at Scilifelab, in a column.
-
Chefen för MHRA lämnar
Ian Hudson, chef för den nationella brittiska läkemedelsmyndigheten meddelar att han lämnar posten i september nästa år.
-
Ökad försäljning för Moberg Pharma
Läkemedelsbolaget visar upp en ökad försäljning år 2014.
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Marie Gårdmark: Big data evidence generation drives change in the EU regulatory system
Rapid developments in technology have led to the possibility for the generation and analysis of vast volumes of data. Will the availability of big data lead to ...
-
Nytillskott på SDS
Katarina Mercer har börjat i SDS som senior regulatory-konsult med Biologicals och Advanced Tissue Medicinal Products som ansvarsområden.
-
They’re all doing it – buying drug research
December 12 the time has come for this year's annual partnering meeting Pharma Outsourcing in Stockholm. In Sweden this is a growing business, with Recipharm as...